Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022
Romy D. Zwittink, Cornelia C. H. Wielders, Daan W. Notermans, Nelianne J. Verkaik, Annelot F. Schoffelen, Sandra Witteveen, Varisha A Ganesh, Angela de Haan, Jeroen Bos, Jacinta M. Bakker, Caroline Schneeberger-van der Linden, Ed J. Kuijper, Sabine C. de Greeff, Antoni P. A. Hendrickx, on behalf of the Dutch CPE and MRSA Surveillance Study Groups
Abstract
Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.